Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001663577-22-000545
Filing Date
2022-09-14
Accepted
2022-09-14 13:42:56
Documents
44
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 abti10ka.htm   iXBRL 10-K/A 774482
2 GRAPHIC image_001.jpg GRAPHIC 2736
3 GRAPHIC image_002.jpg GRAPHIC 3960
4 GRAPHIC image_003.jpg GRAPHIC 5096
10 ex31_1.htm EX-31.1 9010
11 ex31_2.htm EX-31.2 9015
12 ex32_1.htm EX-32.1 5032
  Complete submission text file 0001663577-22-000545.txt   2492111

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE abti-20220331.xsd EX-101.SCH 17273
6 XBRL CALCULATION FILE abti-20220331_cal.xml EX-101.CAL 31617
7 XBRL DEFINITION FILE abti-20220331_def.xml EX-101.DEF 44363
8 XBRL LABEL FILE abti-20220331_lab.xml EX-101.LAB 146945
9 XBRL PRESENTATION FILE abti-20220331_pre.xml EX-101.PRE 121050
37 EXTRACTED XBRL INSTANCE DOCUMENT abti10ka_htm.xml XML 168368
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 333-156091 | Film No.: 221242686
SIC: 2833 Medicinal Chemicals & Botanical Products